JB/CALL/POLE GROU/17.25/0.125/20.09.24 | Market Closed - Swiss Exchange 08:50:00 05/07/2024 pm IST | ||
| 1.79 CHF | +4.07% |
|
| Current month | +16.23% | ||
| 1 month | -9.60% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
POLYPEPTIDE GROUP AG
Latest news about POLYPEPTIDE GROUP AG
More news
| Date | Price | Change |
|---|---|---|
| 05/24/05 | 1.79 | +4.07% |
| 04/24/04 | 1.72 | +6.17% |
| 03/24/03 | 1.62 | +5.88% |
| 02/24/02 | 1.53 | -0.65% |
| 28/24/28 | 1.54 | -4.94% |
Delayed Quote Swiss Exchange
Last update July 05, 2024 at 08:50 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | POLYPEPTIDE GROUP AG |
| Issuer | Bank Julius Bär |
| PPGEJB | |
| ISIN | CH1294277350 |
| Date issued | 06/10/2023 |
| Strike | 17.25 CHF |
| Maturity | 20/09/2024 (76 Days) |
| Parity | 8 : 1 |
| Emission price | 0.5 CHF |
| Emission volume | N/A |
| Settlement | Beides |
| Currency | CHF |
Technical Indicators
| Highest since issue | 2.15 CHF |
|---|---|
| Lowest since issue | 0.25 CHF |
| Spread | 0.01 CHF |
| Spread % | 0.56% |
Company Profile
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Sector
-
Consensus: PolyPeptide Group AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
32.01
EUR
Average target price
26.74
EUR
Spread / Average Target
-16.48%
- Stock Market
- Warrants
- PPGEJB Warrant
